MedPath

ONO-4053

Generic Name
ONO-4053

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Adult Subjects
Interventions
Drug: Placebo
First Posted Date
2012-02-23
Last Posted Date
2012-12-10
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
80
Registration Number
NCT01537172
Locations
🇬🇧

Hammersmith Medicines Research Ltd, London, United Kingdom

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Phase 1
Terminated
Conditions
Healthy Adult Subjects
Interventions
Drug: Placebo
First Posted Date
2011-06-23
Last Posted Date
2012-06-13
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
15
Registration Number
NCT01379586
Locations
🇬🇧

Leeds Clinical Site, Leeds, West Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath